PTC Therapeutics Inc at Bank of America Healthcare Conference Transcript
All right. Good afternoon, everyone. Thank you for joining us today for our last session of the day. My name is Daniele Drago. I'm one of Tazeen Ahmad's associates here at Bank of America, and I have with me today, Matthew Klein, Chief Operating Officer; and Kylie O'Keefe, SVP of Commercial -- Global Commercial and corporate strategy from PTC Therapeutics. So welcome, guys. And maybe we can start by -- you guys can introduce yourself and maybe you can give us a brief overview of the company and key catalysts for the year.
Sure. So thank you very much, Daniele. For those of you who might not be familiar with PTC Therapeutics, we're a global biopharmaceutical company with multiple platforms each built on pioneering science. We are focused on discovering, developing and commercializing innovative therapies for rare disorders while delivering significant value to all of our stakeholders. We've built a robust pipeline of therapies that moves us towards our goal of delivering new therapeutics in a steady stream
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
